ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,156Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 336

$1.23M Total Retail Price of All Prescriptions

Rank: 18 out of 336

709 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 709 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

44% of this provider’s 709 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 16,812 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 2,209 1,022 S3 1 2
AMLODIPINE BESYLATE 1,149 821 2 1
OMEPRAZOLE 823 545 3 3
FUROSEMIDE 790 559 4 4
MELOXICAM 661 450 5 19
LEVOTHYROXINE SODIUM 614 461 6 7
LISINOPRIL 575 364 7 6
ENALAPRIL MALEATE 494 332 8 60
SIMVASTATIN 421 298 9 5
DIOVAN 411 312 10 31
GABAPENTIN 404 213 11 11
PRAVASTATIN SODIUM 398 272 12 10
METOPROLOL SUCCINATE 395 293 13 15
ATENOLOL 356 237 14 26
POTASSIUM CHLORIDE 351 248 15 9
METFORMIN HCL 339 162 16 8
METOPROLOL TARTRATE 307 197 17 16
ATORVASTATIN CALCIUM 275 187 18 14
ZOLPIDEM TARTRATE 272 101 19 18
CITALOPRAM HBR 261 151 20 21
OXYCODONE HCL 253 51 S2 21 184
HYDROCHLOROTHIAZIDE 250 148 22 12
PAROXETINE HCL 245 118 23 64
CARVEDILOL 244 163 24 13
CARISOPRODOL 242 33 R 25 63
TIZANIDINE HCL 236 83 26 83
FAMOTIDINE 220 179 27 73
NEXIUM 218 151 28 24
KLOR-CON 10 212 162 29 75
AMITRIPTYLINE HCL 210 142 R 30 57
CLOPIDOGREL 209 175 31 28
ISOSORBIDE MONONITRATE ER 204 176 32 44
WARFARIN SODIUM 201 137 33 17
LOSARTAN POTASSIUM 197 114 34 22
BENAZEPRIL HCL 191 150 35 59
CRESTOR 190 125 36 25
SERTRALINE HCL 190 99 36 33
ENDOCET 167 84 S2 38 141
TAMSULOSIN HCL 166 118 39 38
LYRICA 166 73 39 70
GLIPIZIDE ER 160 86 41 91
RANITIDINE HCL 159 78 42 36
AMLODIPINE BESYLATE-BENAZEPRIL 158 75 43 47
TRAZODONE HCL 158 60 43 46
DIOVAN HCT 158 139 43 41
TRAMADOL HCL 156 84 46 20
AZITHROMYCIN 155 89 47 58
ALLOPURINOL 146 93 48 30
FENTANYL 143 84 S2 49 120
PANTOPRAZOLE SODIUM 143 93 49 40
PLAVIX 140 114 51 37
CYCLOBENZAPRINE HCL 137 37 R 52 65
CELEBREX 131 98 53 105
LANTUS 131 74 53 56
SYNTHROID 125 96 55 43
GLIPIZIDE 118 62 56 71
SULFAMETHOXAZOLE-TRIMETHOPRIM 116 61 57 89
ROPINIROLE HCL 114 66 58 98
ZETIA 113 74 59 74
CEFUROXIME 113 67 59 177
CYMBALTA 111 18 61 52
METFORMIN HCL ER 108 60 62 61
DILTIAZEM ER 108 84 62 138
LEVOXYL 104 82 64 180
SPIRONOLACTONE 100 34 65 42
DIGOXIN 98 77 66 50
GLIPIZIDE XL 96 29 67 174
POLYETHYLENE GLYCOL 3350 96 70 67 68
DONEPEZIL HCL 96 89 67 27
COMBIVENT 94 64 70 152
GLIMEPIRIDE 92 65 71 29
CLONIDINE HCL 90 56 72 32
FENOFIBRATE 89 49 73 72
NAMENDA 88 88 74 39
METOLAZONE 87 65 75 170
JANUVIA 84 52 76 67
PROAIR HFA 81 44 77 77
AMOXICILLIN 80 42 78 128
TRIAMTERENE-HCTZ 80 59 78 35
SINGULAIR 79 36 80 85
AMIODARONE HCL 78 65 81 117
ADVAIR DISKUS 78 59 81 82
MECLIZINE HCL 77 70 83 96
TERAZOSIN HCL 76 33 84 166
GEMFIBROZIL 76 68 84 115
FLUCONAZOLE 75 25 86 151
HUMULIN N 75 43 86 184
BACLOFEN 75 28 86 179
SPIRIVA 74 55 89 88
LIPITOR 74 63 89 62
OXYBUTYNIN CHLORIDE 73 51 91 153
FLUOXETINE HCL 73 41 91 81
METHADONE HCL 71 0 S2 93 253
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 70 93 23
PREDNISONE 70 42 95 48
OXYCODONE HCL-ACETAMINOPHEN 69 35 S2 96 136
TRICOR 68 34 97 108
NAPROXEN 66 40 98 80
GLYBURIDE-METFORMIN HCL 66 64 R 98 78
PRAMIPEXOLE DIHYDROCHLORIDE 65 61 100 204
ESCITALOPRAM OXALATE 65 27 100 69
SUCRALFATE 63 32 102 192
PROMETHAZINE HCL 63 24 R 102 99
ACTOS 62 32 104 119
DOXAZOSIN MESYLATE 62 46 104 86
DEXILANT 61 26 106 147
HYDRALAZINE HCL 59 47 107 53
DETROL LA 58 39 108 175
FLUTICASONE PROPIONATE 54 37 109 49
PHENYTOIN SODIUM EXTENDED 54 25 109 97
VENTOLIN HFA 53 39 111 130
DILTIAZEM 24HR CD 50 40 112 126
MUPIROCIN 50 26 112 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.